These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 6840477)
1. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease. Baravalle E; Prieto J Gastroenterology; 1983 Jun; 84(6):1483-91. PubMed ID: 6840477 [TBL] [Abstract][Full Text] [Related]
2. Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease. Izumi N; Sato C; Hasumura Y; Takeuchi J Clin Exp Immunol; 1985 Sep; 61(3):585-92. PubMed ID: 3907903 [TBL] [Abstract][Full Text] [Related]
3. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy]. Quecedo L; Costa J; Enríquez de Salamanca R Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696 [TBL] [Abstract][Full Text] [Related]
4. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron. Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda. Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria. Lim HW Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874 [TBL] [Abstract][Full Text] [Related]
8. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease. Kawanishi H; MacDermott RP Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of porphyria cutanea tarda with chloroquine and its effect on associated liver disease: retrospective analysis]. Wolff C; Armas R; Krause P; Parraguez A; Ramón Soto J Rev Med Chil; 1996 Apr; 124(4):456-60. PubMed ID: 9110486 [TBL] [Abstract][Full Text] [Related]
10. Hepatic haem metabolism in porphyria cutanea tarda (PCT): enzymatic studies and their relation to liver ultrastructure. Blekkenhorst GH; Pimstone NR; Webber BL; Eales L Ann Clin Res; 1976; 8 Suppl 17():108-21. PubMed ID: 1008481 [TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda. Franklin MR; Phillips JD; Kushner JP Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724 [TBL] [Abstract][Full Text] [Related]
12. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda]. Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743 [TBL] [Abstract][Full Text] [Related]
13. Urinary porphyrins in liver disease. Ostrowski J; Kosecki P; Martyńska M; Milewski B Scand J Gastroenterol; 1984 Sep; 19(6):862-6. PubMed ID: 6515322 [TBL] [Abstract][Full Text] [Related]